Externally Led Patient-Focused Drug Development (EL-PFDD) Meeting on Infertility and IVF


26 March
2026

10am to
3:30pm

Join Us
Virtually

Externally Led Patient-Focused Drug Development (EL-PFDD) Meeting on Infertility and IVF

26 March 2026,
10am to 3:30pm

Join Us Virtually

Fertility Preservation Toolkit

Thank you for your interest in our toolkits. Please read our Terms of Use carefully as we include information that applies to all our toolkits.

All toolkits are publicly available for individual use without licensing or royalty fees. Such use of toolkits is “single use,” meaning solely for the User’s research, clinical, educational, or other application. User’s email may be added to an email distribution list to receive scientific and updated information about the toolkit(s).

We encourage use of our toolkits. User agrees not to adapt, alter, amend, abridge, modify, condense, make derivative works, or translate toolkits without prior written permission from the Provider. User agrees not to sell or incorporate toolkits into materials that could be sold without prior written consent from the Provider. To inquire about permissions, please email info@a4fp.org.


fertility issues

Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic - blog post image

Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic

During this uncertain and unprecedented time, the oncofertility community is working together to provide up-to-date fertility preservation information for patients and providers. We are aware of the recommendations from ASRM’s COVID-19 Task Force which suggests new IVF cycles not be initiated at this time. While this pause in services does not apply to urgent fertility preservation for patients

Joint Statement from the Alliance for Fertility Preservation and the Oncofertility Consortium on Fertility Preservation for Patients Receiving Gonadotoxic Therapies During the COVID-19 Pandemic Read More »

Treatments for Cancer and Sickle Cell Disease in Boys: Making Sure Their Fertility is Protected - blog post image

Treatments for Cancer and Sickle Cell Disease in Boys: Making Sure Their Fertility is Protected

Recently, scientists discovered that certain treatments for cancer and sickle cell disease destroy the germ cells that eventually go on to develop into sperm in the testes of young boys. This means that the treatment, while important, and potentially lifesaving, may permanently impact their fertility should they want to have children down the road. The study was

Treatments for Cancer and Sickle Cell Disease in Boys: Making Sure Their Fertility is Protected Read More »

Share Your Story! Narrative Inquiry in Bioethics calling for patient stories about cancer and fertility - blog post image

Share Your Story! Narrative Inquiry in Bioethics calling for patient stories about cancer and fertility

The Journal Narrative Inquiry in Bioethics has chosen to dedicate an issue to stories about patients and families who faced fertility issues as a result of a cancer diagnosis and treatment. Because children and young adults may have their future ability to become a parent compromised by cancer treatment, it is important that they understand

Share Your Story! Narrative Inquiry in Bioethics calling for patient stories about cancer and fertility Read More »

New article identifies female patients don’t receive enough fertility information - blog post image

New article identifies female patients don’t receive enough fertility information

Many young adult female cancer survivors want children in the future, but, for a variety of reasons, are unable to undergo fertility preservation before treatment. For those who maintain ovarian function after treatment but are at risk for premature ovarian failure, fertility preservation after treatment may be an option. However, patients cannot avail themselves of

New article identifies female patients don’t receive enough fertility information Read More »